(Flagler Beach, FL) – Rod Spittle, who led the Allianz Championship early in the final round, used his Cure RX Series putter to capture a T-9th Place Finish and collect a check for $45,900.00. Spittle ranked 2nd in Birdies with 18 at the event and had 23 One Putts over the 54 Holes of the tournament (a 42.59% Average).
“My Cure RX Series putter is the most stable putter I have ever used,” said Spittle, “and my putting stats have improved dramatically – I’m saving over 2 strokes per event since I put it in the bag!”
Champions Tour Player, Dana Quigley switched to a Cure RX Series putter recently and has seen a big improvement in his putting as well. Quigley ranked 2nd in One Putt Percentage (48.15%) at the Allianz Championship recording 26 One Putts for the 54 Holes of the tournament and 5th in Putts Per GIR with a 1.607 average.
“The Allianz is our first event of the 2015 Champions Tour season and we’ve already captured our first Top 10,” said Jim Barfield, Vice-President of Tour Operations for Cure Putters. “Each week more and more of the Tour Players are recognizing the benefits of our Higher MOI design and realizing just how much it can help their game!”
Cure RX Series putters all feature an Extremely High MOI design, which is very stable and offers incredible forgiveness for much greater accuracy and distance control, even on extreme mishits. The adjustable weighting system allows a far greater range of weight than any other putter on the market, allowing the golfer to find the perfect weight to suit their stroke and tempo. The Triangulation Alignment, invented by Deane Beman, helps you line up your putt like an arrow for deadly accuracy. With a higher center of gravity and lower loft, Cure Putters deliver a superior roll – getting the ball rolling sooner, helping it stay on the intended line. Cure Putters’ innovative design takes several problematic variables out of the equation and offers incredible forgiveness and control, resulting in a tighter shot dispersion. Golfers of every skill level will putt more consistently, build confidence and achieve better results with a Cure RX Series putter.
About Cure Putters
Cure Putters is a golf putter manufacturer based in Flagler Beach, Florida. Guided by the principle that “Form Follows Function”, Cure Putters takes a no-nonsense, performance driven approach to putter design. Cure RX Series Putters deliver extremely High MOI for greater forgiveness and distance control with the added benefit of adjustability and customization. All of the Cure RX Series putters are CNC milled from a solid block of T-6160 Aircraft Grade Aluminum and 100% Made and Assembled in the USA.
Cure Putters was founded in 2013 by Jeff Ryan, a PGA professional and Steve Davis, a retired architect with a scratch handicap. Deane Beman, Former PGA TOUR Commissioner, joined Cure Putters as part owner and collaborated on the design of the RX2 and subsequent models, which feature Beman’s Triangulation Alignment System – a visual aiming aid that helps reduce the effect of eye dominance. Cure RX Series Putters retail from $199 – $299.
For more information on Cure Putters visit www.cureputters.com.
Media members interested in testing any of the Cure Putters for an editorial review should contact Joe Wieczorek joe@themediagroupinc.com of The Media Group at (847) 956-9090.
Contact:
Joe Wieczorek
The Media Group, Inc.
(847) 956-9090
E-mail: joe@themediagroupinc.com
